Sergei I. Bazhan

Kol'tsovo, NVS, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Artificial COVID-19 T-Cell Immunogen.

Artificial COVID-19 T-Cell Immunogen.

Journal: Bulletin of experimental biology and medicine

Published: March 02, 2023

Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19.

Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19.

Journal: Bulletin of experimental biology and medicine

Published: May 11, 2022

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice.

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice.

Journal: International journal of molecular sciences

Published: January 28, 2022

Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens.

Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens.

Journal: Vaccines

Published: March 10, 2021

Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate.

Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate.

Journal: Vaccines

Published: December 14, 2020

In silico design of influenza a virus artificial epitope-based T-cell antigens and the evaluation of their immunogenicity in mice.

In silico design of influenza a virus artificial epitope-based T-cell antigens and the evaluation of their immunogenicity in mice.

Journal: Journal of biomolecular structure & dynamics

Published: November 23, 2020

Cationic Polymers for the Delivery of the Ebola DNA Vaccine Encoding Artificial T-Cell Immunogen.

Cationic Polymers for the Delivery of the Ebola DNA Vaccine Encoding Artificial T-Cell Immunogen.

Journal: Vaccines

Published: November 02, 2020

Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice.

Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice.

Journal: Vaccines

Published: July 08, 2020

In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice.

In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice.

Journal: Vaccines

Published: March 05, 2019

Design of Artificial Immunogens Containing Melanoma-associated T-cell Epitopes.

Design of Artificial Immunogens Containing Melanoma-associated T-cell Epitopes.

Journal: Current gene therapy

Published: July 25, 2018

Visualization of CombiHIVvac Vaccine Particles Using Electron Microscopy.

Visualization of CombiHIVvac Vaccine Particles Using Electron Microscopy.

Journal: AIDS research and human retroviruses

Published: December 21, 2016

Evaluation of Influenza Vaccination Efficacy: A Universal Epidemic Model.

Evaluation of Influenza Vaccination Efficacy: A Universal Epidemic Model.

Journal: BioMed research international

Published: May 31, 2016

Showing 1-12 of 22

Last Updated: 09/26/2026